Gurung A M, Carr B, Smith I
Directorate of Anaesthesia and Intensive Care, North Staffordshire Hospital, Stoke-on-Trent, UK.
Br J Anaesth. 2001 Dec;87(6):926-8. doi: 10.1093/bja/87.6.926.
We conducted a retrospective study of platelet count in 226 patients admitted for critical care over a 5-month period, to explore the incidence of thrombocytosis and its relation to admission category, duration of ICU stay and outcome. Our findings indicate that thrombocytosis is not rare in ICU patients. At least one platelet count greater than 450x10(9) litre(-1) was found in 21.7% of patients and was associated with lower ICU mortality (P=0.003), lower hospital mortality (P=0.006), but longer duration of ICU stay (P<0.0001). Thrombocytosis may serve as an independent predictor of favourable outcome in ICU patients.
我们对226名在5个月期间因重症监护入院的患者的血小板计数进行了回顾性研究,以探讨血小板增多症的发生率及其与入院类别、重症监护病房(ICU)住院时间和预后的关系。我们的研究结果表明,血小板增多症在ICU患者中并不罕见。在21.7%的患者中发现至少有一次血小板计数大于450×10⁹/升,且与较低的ICU死亡率(P=0.003)、较低的医院死亡率(P=0.006)相关,但ICU住院时间较长(P<0.0001)。血小板增多症可能是ICU患者预后良好的独立预测指标。